endomorphin 2,
endomorphin-2,
l-phenylalaninamide, l-tyrosyl-l-prolyl-l-phenylalanyl-,
l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide,
l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide, (-)-,
tetrapeptide-15,
Tyr-Pro-Phe-Phe-NH2,
tyrosyl-prolyl-phenylalanyl-phenylalaninamide,
Endomorphin 2,
Endomorphin-2,
141801-26-5,
Tyr-Pro-Phe-Phe-NH2,
H-Tyr-Pro-Phe-Phe-NH2,
UNII-3PH5M0466G,
CHEMBL333357,
3PH5M0466G,
L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-phenylalanyl-,
L-Phenylalaninamide,L-tyrosyl-L-prolyl-L-phenylalanyl-,
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide,
(S)-N-((S)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide,
tyrosyl-prolyl-phenylalanyl-phenylalaninamide,
AC1NSJYN,
GTPL3668,
DTXSID70415506,
HY-P0186,
BDBM50139013,
MFCD01321064,
ZINC14951634,
AKOS024456356,
CS-7089,
NCGC00163677-01,
NCGC00163677-02,
LS-105738,
(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-N-[(1S)-1-carbamoyl-2-phenylethyl]-3-phenylpropanamide,
(S)-1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic acid [(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide,
1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylicacid[1-((S)-(S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide,
tetrapeptide-15,
D00TNR,
CID5311081,
B5045,
C105294,
l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide,
l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide, (-)-,